Ogier acts for EastBridge Investment Group on merger with Cellular Biomedicine Group

Ogier in the BVI has advised OTCQB listed company, EastBridge Investment Group Corporation (EBIG) on the BVI legal aspects of its merger with BVI incorporated Cellular Biomedicine Group, Ltd ("CBMG"), a company which develops proprietary cell therapies for the treatment of certain cancer and degenerative diseases.  The merger was structured as a merger between CBMG and CBMG Acquisition Limited, a BVI incorporated wholly-owned subsidiary of EBIG set up for the purposes of the transaction.

Ogier acted with Ellenoff Grossman & Schole LLP for EastBridge Investment Group with Richardson & Patel LLP  acting for Cellular Biomedicine Group, Ltd.  The Ogier team comprised Simon Schilder (Partner) and Marie-Claire Fudge (Managing Associate).